Colon Cancer Screening
A colonoscopy is the primary and most effective screening technique used to screen patients for colorectal cancer. Learn more in this video from Dr. Ted Hong, GI Radiation Oncologist at the Mass General Cancer Center.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Clinical Interests:
Treats:
Clark Center for Radiation Oncology
100 Blossom Street
Boston, MA 02114-2606
Phone: 617-726-6050
Phone: 617-726-8650
Fax: 617-726-3603
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
A colonoscopy is the primary and most effective screening technique used to screen patients for colorectal cancer. Learn more in this video from Dr. Ted Hong, GI Radiation Oncologist at the Mass General Cancer Center.
Ted Hong, MD, radiation oncologist and avid hockey player discusses explains how the Mass General Cancer Center’s multidisciplinary approach to developing care plans for patients is so beneficial to the patient. He also talks about his love for the game of hockey and the beauty of teamwork.
Dr. Hong and Dr. Qadan discuss how the Cancer Center has had to postpone some cancer surgeries due to the COVID-19 pandemic, how these patients are being managed and how the Cancer Center is prioritizing each and every patient going forward.
More than 680 physicians and guests gathered to celebrate at the ninth physician recognition dinner and the presentation of the McGovern Awards for Clinical Excellence.
A task force commissioned by ASTRO reported the findings of its review on opportunities to expand the number of clinical trials that include radiation therapy in combination with new cancer drugs.